Chemkart India IPO Date, Price, Details
Chemkart India is launching its IPO on July 7, 2025, with the subscription window closing on July 9, 2025. This is a Book Built Issue, through which the company plans to raise approximately ₹80.08 crores. The issue includes a fresh equity issuance worth ₹64.48 crores, along with an offer for sale of 6,29,200 equity shares, each having a face value of ₹10.
The price band has been set between ₹236 to ₹248 per share. Allocation of shares is divided as follows: 50% for Qualified Institutional Buyers (QIBs), 15% for High Net-worth Individuals (HNIs), and 35% for retail investors.
The basis of allotment will be finalized on July 10, 2025, and the shares are expected to be listed on the BSE on July 14, 2025.
In terms of financial performance, the company posted a revenue of ₹205.46 crores in FY25, up from ₹132.83 crores in FY24. Net profit also saw significant growth, rising from ₹14.52 crores in FY24 to ₹24.26 crores in FY25.
Chemkart India IPO Market Lot Size
The Chemkart India IPO minimum market lot is 600 shares with ₹1,48,800 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 600 | ₹1,48,800 |
Retail Maximum | 1 | 600 | ₹1,48,800 |
S-HNI Minimum | 2 | 1,200 | ₹2,97,600 |
Chemkart India IPO Details
IPO Open Date: | July 7, 2025 |
IPO Close Date: | July 9, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹236 to ₹248 Per Share |
Issue Size: | Approx ₹80.08 Crores |
Fresh Issue: | Approx ₹64.48 Crores |
Offer for Sale: | Approx 6,29,200 Equity Shares |
Issue Type: | Book Build Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Chemkart India IPO Valuation – FY2025 (KPI)
Chemkart India IPO Valuation Highlights: EPS, P/E Ratio, RoNW, and NAV Explained
KPI | Values |
ROE: | 0.59 |
ROCE: | 0.49 |
EBITDA Margin: | 16.12% |
PAT Margin: | 0.12 |
Debt to equity ratio: | 0.32 |
Earning Per Share (EPS): | ₹25.54 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 45.52% |
Net Asset Value (NAV): | ₹56.10 |
Chemkart India IPO Company Financial Report
In the financial year 2025, Chemkart India recorded a revenue of ₹205.46 crores, reflecting strong growth from ₹132.83 crores in the previous year. The company’s net profit also rose significantly, reaching ₹24.26 crores in FY25, compared to ₹14.52 crores in FY24.
(All figures are in ₹ Crores)
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹87.43 | ₹80.11 | ₹5.48 | ₹24.54 |
2023 | ₹131.69 | ₹121.17 | ₹7.66 | ₹37.48 |
2024 | ₹132.83 | ₹112.87 | ₹14.52 | ₹53.51 |
2025 | ₹205.46 | ₹172.86 | ₹24.26 | ₹86.12 |
Chemkart India IPO Dates
The Chemkart India IPO date is July 7 and the close date is July 9. The Chemkart India IPO allotment will be finalized on July 10 and the IPO listing on July 14.
IPO Open Date: | July 7, 2025 |
IPO Close Date: | July 9, 2025 |
Basis of Allotment: | July 10, 2025 |
Refunds: | July 11, 2025 |
Credit to Demat Account: | July 11, 2025 |
IPO Listing Date: | July 14, 2025 |
Promoters of Chemkart India IPO
The promoters of the company are Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta, and Mr. Shaileesh Vinodrai Mehta.
About Chemkart India IPO
Founded in 2015, Chemkart India Limited is a Mumbai-based company specializing in the distribution of nutritional, health, and sports supplement ingredients. The company plays a key role in catering to the nutrition and wellness industry, offering a diverse range of products aimed at improving health and well-being.
Chemkart operates primarily in the B2B space, supplying high-quality raw materials used by manufacturers in producing various supplements—including sports nutrition, vitamins, proteins, and herbal health products.
Their product portfolio spans across seven main categories:
Amino Acids
Health Supplements
Herbal Extracts
Nucleotides
Proteins
Sports Nutrition
Vitamins
The company emphasizes a customer-centric approach and provides grinding, blending, and packaging services from its modern and hygienic facility located in Bhiwandi, Mumbai. This facility includes a 28,259.16 sq. ft. warehouse equipped for efficient processing, labeling, and sealing operations.
As of March 31, 2025, Chemkart India employs a team of 40 professionals, supporting its growing presence in the nutrition and supplement ingredient sector.
Peer Group Comparison
Company | EPS | PE Ratio | RoNW % | NAV | Income |
NA | – | – | – | – | – Cr. |
Objects of the IPO
To fund capital expenditure for establishing a manufacturing unit by investing in its wholly-owned subsidiary, Easy Raw Materials Private Limited
To repay or prepay, in full or in part, existing borrowings taken by the company
To meet general corporate requirements and support overall business operations
Merchant Bankers
- Smart Horizon Capital Advisors Private Limited
Company Address
Chemkart India Limited
Office No. 403/404,
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East), Mumbai – 400055
Mumbai, Maharashtra
Phone: +91 9136383828
Email: [email protected]
Website: https://chemkart.com/
Chemkart India IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Check Grey market premium at below
(GMP)